Akkermansia Muciniphila: Promises and Pitfallsfor Next-generation Beneficial Microorganisms

Overview

Journal Arch Microbiol

Specialty Microbiology

Date 2025 Mar 3

PMID 40032707

Authors

Yantong Liu

Zonglun Li

Sze Ching Lee

Shurui Chen

Feifei Li

Affiliations

Soon will be listed here.

Abstract

Akkermansia muciniphila, a microorganism ubiquitously colonizing the mucosal layer of the human gut, has garnered significant scientific interest as a promising candidate for probiotic therapeutics. Its persistent identification in both laboratory and living organism studies underscores its potential physiological benefits, positioning it as a bacterium of paramount importance in promoting host health. This review examines the diversity and abundance of gut microbiota members, emphasizing the identification of microbial species engaged in cross-feeding networks with A. muciniphila. Insightful exploration into the mechanisms of cross-feeding, including mucin-derived nutrient exchange and metabolite production, unveils the intricate dynamics shaping microbial community stability. Such interactions contribute not only to the availability of essential nutrients within the gut environment but also to the production of metabolites influencing microbial community dynamics and host health. In conclusion, the cumulative evidence from in vitro and in vivo perspectives substantiates the notion that A. muciniphila holds tremendous promise as a next-generation probiotic. By leveraging its unique physiological benefits, particularly in mucosal health and metabolic regulation, A. muciniphila stands poised to revolutionize the landscape of probiotic interventions for enhanced host well-being.

References

Alard J, Lehrter V, Rhimi M, Mangin I, Peucelle V, Abraham A . Beneficial metabolic effects of selected probiotics on diet-induced obesity and insulin resistance in mice are associated with improvement of dysbiotic gut microbiota. Environ Microbiol. 2015; 18(5):1484-97. DOI: 10.1111/1462-2920.13181. View

Allen-Vercoe E, Daigneault M, White A, Panaccione R, Duncan S, Flint H . Anaerostipes hadrus comb. nov., a dominant species within the human colonic microbiota; reclassification of Eubacterium hadrum Moore et al. 1976. Anaerobe. 2012; 18(5):523-9. DOI: 10.1016/j.anaerobe.2012.09.002. View

Alsharairi N . Therapeutic Potential of Gut Microbiota and Its Metabolite Short-Chain Fatty Acids in Neonatal Necrotizing Enterocolitis. Life (Basel). 2023; 13(2). PMC: 9959300. DOI: 10.3390/life13020561. View

Bae M, Cassilly C, Liu X, Park S, Tusi B, Chen X . Akkermansia muciniphila phospholipid induces homeostatic immune responses. Nature. 2022; 608(7921):168-173. PMC: 9328018. DOI: 10.1038/s41586-022-04985-7. View

Becken B, Davey L, Middleton D, Mueller K, Sharma A, Holmes Z . Genotypic and Phenotypic Diversity among Human Isolates of Akkermansia muciniphila. mBio. 2021; 12(3). PMC: 8262928. DOI: 10.1128/mBio.00478-21. View

Belizario J, Napolitano M . Human microbiomes and their roles in dysbiosis, common diseases, and novel therapeutic approaches. Front Microbiol. 2015; 6:1050. PMC: 4594012. DOI: 10.3389/fmicb.2015.01050. View

Belzer C . Nutritional strategies for mucosal health: the interplay between microbes and mucin glycans. Trends Microbiol. 2021; 30(1):13-21. DOI: 10.1016/j.tim.2021.06.003. View

Belzer C, Chia L, Aalvink S, Chamlagain B, Piironen V, Knol J . Microbial Metabolic Networks at the Mucus Layer Lead to Diet-Independent Butyrate and Vitamin B Production by Intestinal Symbionts. mBio. 2017; 8(5). PMC: 5605934. DOI: 10.1128/mBio.00770-17. View

Blacher E, Bashiardes S, Shapiro H, Rothschild D, Mor U, Dori-Bachash M . Potential roles of gut microbiome and metabolites in modulating ALS in mice. Nature. 2019; 572(7770):474-480. DOI: 10.1038/s41586-019-1443-5. View

10.

Breugelmans T, Oosterlinck B, Arras W, Ceuleers H, De Man J, Hold G . The role of mucins in gastrointestinal barrier function during health and disease. Lancet Gastroenterol Hepatol. 2022; 7(5):455-471. DOI: 10.1016/S2468-1253(21)00431-3. View

11.

Brodmann T, Endo A, Gueimonde M, Vinderola G, Kneifel W, de Vos W . Safety of Novel Microbes for Human Consumption: Practical Examples of Assessment in the European Union. Front Microbiol. 2017; 8:1725. PMC: 5601064. DOI: 10.3389/fmicb.2017.01725. View

12.

Cani P, de Vos W . Next-Generation Beneficial Microbes: The Case of . Front Microbiol. 2017; 8:1765. PMC: 5614963. DOI: 10.3389/fmicb.2017.01765. View

13.

Cani P, Depommier C, Derrien M, Everard A, de Vos W . Akkermansia muciniphila: paradigm for next-generation beneficial microorganisms. Nat Rev Gastroenterol Hepatol. 2022; 19(10):625-637. DOI: 10.1038/s41575-022-00631-9. View

14.

Chang Y, Yang Y, Xu N, Mu H, Zhang H, Duan J . Improved viability of Akkermansia muciniphila by encapsulation in spray dried succinate-grafted alginate doped with epigallocatechin-3-gallate. Int J Biol Macromol. 2020; 159:373-382. DOI: 10.1016/j.ijbiomac.2020.05.055. View

15.

Chen T, Wang R, Duan Z, Yuan X, Ding Y, Feng Z . Protects Against Psychological Disorder-Induced Gut Microbiota-Mediated Colonic Mucosal Barrier Damage and Aggravation of Colitis. Front Cell Infect Microbiol. 2021; 11:723856. PMC: 8551916. DOI: 10.3389/fcimb.2021.723856. View

16.

Chelakkot C, Choi Y, Kim D, Park H, Ghim J, Kwon Y . Akkermansia muciniphila-derived extracellular vesicles influence gut permeability through the regulation of tight junctions. Exp Mol Med. 2018; 50(2):e450. PMC: 5903829. DOI: 10.1038/emm.2017.282. View

17.

Chia L, Hornung B, Aalvink S, Schaap P, de Vos W, Knol J . Deciphering the trophic interaction between Akkermansia muciniphila and the butyrogenic gut commensal Anaerostipes caccae using a metatranscriptomic approach. Antonie Van Leeuwenhoek. 2018; 111(6):859-873. PMC: 5945754. DOI: 10.1007/s10482-018-1040-x. View

18.

Cirstea M, Radisavljevic N, Finlay B . Good Bug, Bad Bug: Breaking through Microbial Stereotypes. Cell Host Microbe. 2018; 23(1):10-13. DOI: 10.1016/j.chom.2017.12.008. View

19.

Aron R, Abid A, Vesa C, Nechifor A, Behl T, Ghitea T . Recognizing the Benefits of Pre-/Probiotics in Metabolic Syndrome and Type 2 Diabetes Mellitus Considering the Influence of as a Key Gut Bacterium. Microorganisms. 2021; 9(3). PMC: 8002498. DOI: 10.3390/microorganisms9030618. View

20.

Davey L, Malkus P, Villa M, Dolat L, Holmes Z, Letourneau J . A genetic system for Akkermansia muciniphila reveals a role for mucin foraging in gut colonization and host sterol biosynthesis gene expression. Nat Microbiol. 2023; 8(8):1450-1467. PMC: 11741908. DOI: 10.1038/s41564-023-01407-w. View